The Lancet. MicrobeHumansIvermectinScabiesMass Drug AdministrationMale
Direct and indirect protection against scabies through ivermectin mass drug administration designed for malaria in Mozambique: a substudy nested within a cluster-randomised, controlled trial.
Joanna Furnival-Adams, Amelia Houana, Francisco Saute, Eldo Elobolobo, Matthew Rudd, Patricia Nicolas, Julia Montaña, Samuel Martinho, Hansel Mundaca, Jenisse Mbanze, Arlindo Soares, Saimado Imputiua, Paula Ruiz-Castillo, Marta Ribes, Almudena Sanz
Published: 202510.1016/j.lanmic.2025.101189
Abstract
BACKGROUND: Ivermectin is an endectocide effective against scabies that is under evaluation as a malaria vector control tool. During the BOHEMIA malaria trial, we did a substudy with the aim of assessing the efficacy of ivermectin mass drug administr…
Preview only. Read the full abstract at the source